{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:24:28Z","timestamp":1772252668173,"version":"3.50.1"},"reference-count":61,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: It remains uncertain whether Kaposi sarcoma (KS) is a true neoplasm, in that it regresses after removal of the stimulus to growth (as HHV8) when immunosuppression is reduced. We aimed to summarize the available evidence on somatic mutations and clonality within KS to assess whether KS is a neoplasm or not. Methods: Medline and Web of Science were searched until September 2020 for articles on clonality or mutation in KS. Search strings were supervised by expert librarians, and two researchers independently performed study selection and data extraction. An adapted version of the QUADAS2 tool was used for methodological quality appraisal. Results: Of 3077 identified records, 20 publications reported on relevant outcomes and were eligible for qualitative synthesis. Five studies reported on clonality, 10 studies reported on various mutations, and 5 studies reported on chromosomal aberrations in KS. All studies were descriptive and were judged to have a high risk of bias. There was considerable heterogeneity of results with respect to clonality, mutation and cytogenetic abnormalities as well as in terms of types of lesions and patient characteristics. Conclusions: While KS certainly produces tumours, the knowledge is currently insufficient to determine whether KS is a clonal neoplasm (sarcoma), or simply an aggressive reactive virus-driven lesion.<\/jats:p>","DOI":"10.3390\/cancers14051201","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:00:40Z","timestamp":1645783240000},"page":"1201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clonality, Mutation and Kaposi Sarcoma: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Blanca Iciar","family":"Indave Ruiz","sequence":"first","affiliation":[{"name":"International Agency for Research on Cancer (IARC), World Health Organization, 69372 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-2336","authenticated-orcid":false,"given":"Subasri","family":"Armon","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), World Health Organization, 69372 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), World Health Organization, 69372 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-9069","authenticated-orcid":false,"given":"Lesley","family":"Uttley","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield S1 4DA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-4553","authenticated-orcid":false,"given":"Valerie A.","family":"White","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), World Health Organization, 69372 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A.","family":"Cree","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), World Health Organization, 69372 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13555-016-0152-3","article-title":"An Update on Kaposi\u2019s Sarcoma: Epidemiology, Pathogenesis and Treatment","volume":"6","author":"Curtiss","year":"2016","journal-title":"Dermatol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/014107688607900910","article-title":"A history of Kaposi\u2019s sarcoma","volume":"79","author":"Shiels","year":"1986","journal-title":"J. R. Soc. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-03502-0_1","article-title":"AIDS-Associated Malignancies","volume":"177","author":"Vangipuram","year":"2019","journal-title":"Cancer Treat. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ijd.14080","article-title":"Epidemiology of Kaposi sarcoma: Review and description of the nonepidemic variant","volume":"58","author":"Vangipuram","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20160275","DOI":"10.1098\/rstb.2016.0275","article-title":"Kaposi sarcoma herpesvirus pathogenesis","volume":"372","author":"Mariggio","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Etta, E.M., Alayande, D.P., Mavhandu-Ramarumo, L.G., Gachara, G., and Bessong, P.O. (2018). HHV-8 Seroprevalence and Genotype Distribution in Africa, 1998(-)2017: A Systematic Review. Viruses, 10.","DOI":"10.3390\/v10090458"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Phipps, W., Ssewankambo, F., Nguyen, H., Saracino, M., Wald, A., Corey, L., Orem, J., Kambugu, A., and Casper, C. (2010). Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013936"},{"key":"ref_9","first-page":"611","article-title":"Tumor seminar","volume":"46","author":"Willis","year":"1950","journal-title":"Tex. State J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2018.05.001","article-title":"Multiclonal tumor origin: Evidence and implications","volume":"777","author":"Parsons","year":"2018","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/labinvest.2011.118","article-title":"Nodular fasciitis: A novel model of transient neoplasia induced by MYH9-USP6 gene fusion","volume":"91","author":"Chou","year":"2011","journal-title":"Lab. Investig. A J. Tech. Methods Pathology."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"010404","DOI":"10.7189\/jogh.10.010404","article-title":"Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature","volume":"10","author":"Winter","year":"2020","journal-title":"J. Glob. Health."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: Statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal Patterns of Selection in Cancer and Somatic Tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-019-0648-4","article-title":"Somatic mutation and clonal expansions in human tissues","volume":"11","author":"Martincorena","year":"2019","journal-title":"Genome Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000260905","article-title":"TP53 codon 72 polymorphism in classic, endemic and epidemic Kaposi\u2019s sarcoma in African and Caucasian patients","volume":"77","author":"Tornesello","year":"2009","journal-title":"Oncology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1749-6632.1984.tb37140.x","article-title":"Kaposi\u2019s sarcoma in Sardinia: An epidemiologic and genetic investigation","volume":"437","author":"Cerimele","year":"1984","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jcp.50.8.664","article-title":"Molecular analysis of clonality in Kaposi\u2019s sarcoma","volume":"50","author":"Delabesse","year":"1997","journal-title":"J. Clin. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.12659\/MSMBR.894089","article-title":"Use of X-Chromosome Inactivation Pattern to Analyze the Clonality of 14 Female Cases of Kaposi Sarcoma","volume":"21","author":"Yuan","year":"2015","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.95.14.8257","article-title":"Evidence for multiclonality in multicentric Kaposi\u2019s sarcoma","volume":"95","author":"Gill","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","first-page":"S74","article-title":"Clonality of aids-related kaposis-sarcoma","volume":"11","author":"Rabkin","year":"1995","journal-title":"Aids Res. Hum. Retrovir."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199704033361403","article-title":"Monoclonal origin of multicentric Kaposi\u2019s sarcoma lesions","volume":"336","author":"Rabkin","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_28","first-page":"921","article-title":"Gene amplification and multiple mutations of the K-ras oncogene in Kaposi\u2019s sarcoma","volume":"14","author":"Nicolaides","year":"1994","journal-title":"Anticancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/modpathol.3880074","article-title":"FGF4 and INT2 oncogenes are amplified and expressed in Kaposi\u2019s sarcoma","volume":"13","author":"Larramendy","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI116279","article-title":"Expression of int-2 oncogene in Kaposi\u2019s sarcoma lesions","volume":"91","author":"Huang","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/scbi.2000.0329","article-title":"Cytokine-mediated growth promotion of Kaposi\u2019s sarcoma and primary effusion lymphoma","volume":"10","author":"Ensoli","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1468-3083.2012.04672.x","article-title":"c-myc in Kaposi\u2019s sarcoma: Analyses by fluorescent in situ hybridization and immunohistochemistry","volume":"28","author":"Feller","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1684\/ejd.2014.2375","article-title":"Familial Kaposi\u2019s Sarcoma in HHV8 infected subjects presenting the G-174C allele of the IL-6 promoter: A possible role for EBV?","volume":"24","author":"Latini","year":"2014","journal-title":"Eur. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00000372-199708000-00009","article-title":"Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi\u2019s sarcoma","volume":"19","author":"Li","year":"1997","journal-title":"Am. J. Dermatopathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.1994.1466","article-title":"Occurrence of human papillomavirus and p53 gene mutations in Kaposi\u2019s sarcoma","volume":"203","author":"Scinicariello","year":"1994","journal-title":"Virology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02782199","article-title":"Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma","volume":"17","author":"Kaaya","year":"2000","journal-title":"Med. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/0959-8049(92)90030-6","article-title":"Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi\u2019s sarcoma","volume":"28a","author":"Kaaya","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2133.1995.tb08709.x","article-title":"Flow cytometric DNA analysis of classic and steroid-induced Kaposi\u2019s sarcoma","volume":"132","author":"Reizis","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/01.aids.0000244199.72887.3d","article-title":"CGH of microdissected Kaposi\u2019s sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages","volume":"20","author":"Pyakurel","year":"2006","journal-title":"AIDS"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/1097-0142(19920201)69:3<793::AID-CNCR2820690330>3.0.CO;2-A","article-title":"A histologic and flow cytometric study of Kaposi\u2019s sarcoma","volume":"69","author":"Bisceglia","year":"1992","journal-title":"Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ijc.21969","article-title":"Lymphatic and vascular origin of Kaposi\u2019s sarcoma spindle cells during tumor development","volume":"119","author":"Pyakurel","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/ebmed-2016-110401","article-title":"New evidence pyramid","volume":"21","author":"Murad","year":"2016","journal-title":"Evid. Based Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast Reconstr. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.virol.2019.07.011","article-title":"Association of polymorphisms in NF\u03baB1 promoter and NF\u03baBIA gene with the development of antibodies against HHV-8 in HIV-infected individuals","volume":"535","author":"Goncales","year":"2019","journal-title":"Virology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2016-06-719716","article-title":"iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease","volume":"129","author":"Sbihi","year":"2017","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/pbc.25779","article-title":"Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8","volume":"63","author":"Jackson","year":"2016","journal-title":"Pediatric Blood Cancer"},{"key":"ref_47","first-page":"253","article-title":"Fulminant HHV-8 associated Castleman\u2019s disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome","volume":"17","author":"Barbarov","year":"2015","journal-title":"IMAJ"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/1066896909341803","article-title":"Synchronous Follicular Lymphoma, Kaposi Sarcoma, and Castleman\u2019s Disease in a HIV-Negative Patient With EBV and HHV-8 Coinfection","volume":"19","author":"Koreishi","year":"2011","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Jain, V., Plaisance-Bonstaff, K., Sangani, R., Lanier, C., Dolce, A., Hu, J., Brulois, K., Haecker, I., Turner, P., and Renne, R. (2016). A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants. Viruses, 8.","DOI":"10.3390\/v8020054"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/1097-0142(20011215)92:12<3076::AID-CNCR10117>3.0.CO;2-D","article-title":"Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies","volume":"92","author":"Katano","year":"2001","journal-title":"Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.18632\/oncotarget.7248","article-title":"MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR","volume":"7","author":"Krause","year":"2016","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mui, U.N., Haley, C.T., and Tyring, S.K. (2017). Viral Oncology: Molecular Biology and Pathogenesis. J. Clin. Med., 6.","DOI":"10.3390\/jcm6120111"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1590\/abd1806-4841.20165026","article-title":"Exome sequence analysis of Kaposiform hemangioendothelioma: Identification of putative driver mutations","volume":"91","author":"Egashira","year":"2016","journal-title":"An. Bras. De Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Naipauer, J., Salyakina, D., Journo, G., Rosario, S., Williams, S., Abba, M., Shamay, M., and Mesri, E.A. (2020). High-throughput sequencing analysis of a \u201chit and run\u201d cell and animal model of KSHV tumorigenesis. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008589"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s004030050257","article-title":"p53 protein overexpression is a common but late event in the pathogenesis of iatrogenic and AIDS-related Kaposi\u2019s sarcoma","volume":"289","author":"Noel","year":"1997","journal-title":"Arch. Dermatol. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","article-title":"Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)","volume":"93","author":"Russo","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9071(199804)54:4<300::AID-JMV10>3.0.CO;2-J","article-title":"Consistent polymerase chain reaction-single-strand conformation polymorphism pattern of human herpesvirus-8 in the course of classical Kaposi\u2019s sarcoma assumes its clonal origin","volume":"54","author":"Juhasz","year":"1998","journal-title":"J. Med. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jnci\/djm045","article-title":"Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma","volume":"99","author":"Duprez","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jnci\/92.9.729","article-title":"Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi\u2019s sarcoma and other diseases","volume":"92","author":"Judde","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(86)91436-4","article-title":"Kaposi\u2019s sarcoma: A reversible hyperplasia","volume":"2","author":"Brooks","year":"1986","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/87.13.974","article-title":"Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi\u2019s sarcoma","volume":"87","author":"Gill","year":"1995","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/5\/1201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:27:23Z","timestamp":1760135243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/5\/1201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["cancers14051201"],"URL":"https:\/\/doi.org\/10.3390\/cancers14051201","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742387671.793596227","asserted-by":"object"}]},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}